Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Drug Deliv ; 10(6): 732-41, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23855499

RESUMO

Although release profiles of drug from hydrophilic matrices have been well recognized, the visual distribution of hydroxypropylmethylcellulose (HPMC) and atoms inside of internal structures of hydrophilic HPMC matrices has not been characterized. In this paper, drug release mechanism from HPMC matrix tablet was investigated based on the release behaviors of HPMC, physical properties of gelled HPMC tablet and atomic distributions of formulation components using diverse instruments. A matrix tablet consisting of hydroxypropyl methylcellulose (HPMC 6, 4,000 and 100,000 mPa·s), chlorpheniramine maleate (CPM) as a model and fumed silicon dioxide (Aerosil(®) 200) was prepared via direct compression. The distribution of atoms and HPMC imaging were characterized using scanning electron microscope (SEM)/ energy-dispersive X-ray spectroscopy (EDX), and near-infrared (NIR) analysis, respectively as a function of time. A texture analyzer was also used to characterize the thickness and maintenance of gel layer of HPMC matrix tablet. The HPMC matrix tablets showed Higuchi release kinetics with no lag time against the square root of time. High viscosity grades of HPMC gave retarded release rate because of the greater swelling and gel thickness as characterized by texture analyzer. According to the NIR imaging, low-viscosity-grade HPMC (6 mPa·s) quickly leached out onto the surface of the tablet, while the high-viscosity-grade HPMC (4000 mPa·s) formed much thicker gel layer around the tablet and maintained longer via slow erosion, resulting in retarded drug release. The atomic distribution of the drug (chlorine, carbon, oxygen), HPMC (carbon, oxygen) and silicon dioxide (silica, oxygen) and NIR imaging of HPMC corresponded with the dissolution behaviors of drug as a function of time. The use of imaging and texture analyses could be applicable to explain the release- modulating mechanism of hydrophilic HPMC matrix tablets.


Assuntos
Clorfeniramina/administração & dosagem , Portadores de Fármacos/química , Excipientes/química , Metilcelulose/análogos & derivados , Química Farmacêutica , Clorfeniramina/química , Preparações de Ação Retardada , Composição de Medicamentos/métodos , Interações Hidrofóbicas e Hidrofílicas , Derivados da Hipromelose , Metilcelulose/química , Microscopia Eletrônica de Varredura , Dióxido de Silício/química , Espectrometria por Raios X , Espectroscopia de Luz Próxima ao Infravermelho , Comprimidos , Viscosidade
2.
Int J Pharm ; 450(1-2): 79-86, 2013 Jun 25.
Artigo em Inglês | MEDLINE | ID: mdl-23612354

RESUMO

Poorly water-soluble drug with a short half-life such as isradipine (IDP) offer challenges in the controlled release formulation because of low dissolution rate and poor bioavailability. Self-emulsifying solid dispersions (SESD) of IDP consisted of surfactant and fatty acid in poloxamer 407 (POX 407) as a carrier and were manufactured by the melting method. Then, controlled release HPMC matrix tablet containing SESD were prepared via direct compression. The dissolution behaviors and in vivo bioavailability of controlled release matrix tablet in healthy human volunteers were investigated. The physical properties of solid dispersion were also examined using differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). It was shown that structure of IDP was amorphous in the solid dispersion. The dissolution rate of IDP from SESD was markedly enhanced because of increased solubility and wetting effect. Controlled release HPMC matrix tablets containing SESD released drug in a controlled manner and were stable during storage over 3 months at 40 °C/75% RH. Furthermore, the tablet containing 5mg IDP SESD showed significantly increased oral bioavailability and extended plasma concentration compared with the marketed 5 mg Dynacirc(®) capsule. A combined method of solid dispersion and controlled release technology could provide versatile dosage formulations containing IDP with poor water solubility and short half-life.


Assuntos
Bloqueadores dos Canais de Cálcio/química , Bloqueadores dos Canais de Cálcio/farmacocinética , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Isradipino/química , Isradipino/farmacocinética , Adulto , Anti-Hipertensivos/sangue , Anti-Hipertensivos/química , Anti-Hipertensivos/farmacocinética , Disponibilidade Biológica , Bloqueadores dos Canais de Cálcio/sangue , Varredura Diferencial de Calorimetria , Excipientes/química , Humanos , Isradipino/sangue , Ácido Oleico/química , Polímeros/química , Difração de Pó , Dióxido de Silício/química , Solubilidade , Tensoativos/química , Comprimidos , Difração de Raios X , Adulto Jovem
3.
Ther Deliv ; 1(1): 51-62, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22816119

RESUMO

BACKGROUND: The aim of this study was to investigate the physicochemical properties of polyethylene oxide (PEO)-based controlled release solid dispersions (CR-SDs) containing aceclofenac, Gelucire 44/14, poloxamer 407 and pH modifier (Na2CO3). RESULTS: The immediate release solid dispersions containing the pH modifier greatly enhanced the drug dissolution rate to approximately 100%, while the CR-SDs with PEO showed controlled release. A bigger droplet size and a higher surface charge for the CR-SDs were observed compared with the immediate release solid dispersions. The pH modifier played an important role in modulating the release rate of the drug through changes in the drug crystallinity and the hydrogen-bonding interaction, as well as the microenvironmental pH. Near-infrared images revealed a modulation of the PEO concentration to preserve the pH modifier within the system for controlled release of the drug. CONCLUSION: The dissolution process of PEO-based solid dispersions containing a water-insoluble drug was governed by the changing net effect of the microenvironmental pH, the surface charge, the particle size and the release rate of the pH modifier, as well as the function of PEO in controlling drug release.


Assuntos
Anti-Inflamatórios não Esteroides/química , Diclofenaco/análogos & derivados , Portadores de Fármacos , Polietilenoglicóis/química , Solventes/química , Água/química , Química Farmacêutica , Preparações de Ação Retardada , Diclofenaco/química , Composição de Medicamentos , Ligação de Hidrogênio , Concentração de Íons de Hidrogênio , Cinética , Tamanho da Partícula , Poloxâmero/química , Bicarbonato de Sódio/química , Solubilidade , Propriedades de Superfície , Tecnologia Farmacêutica/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...